Skip to main content
Log in

What’s new in status epilepticus?

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bleck TP (2005) Refractory status epilepticus. Curr Opin Crit Care 11:117–120

    Article  PubMed  Google Scholar 

  2. Rossetti AO, Lowenstein DH (2011) Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 10:922–930

    Article  PubMed Central  PubMed  Google Scholar 

  3. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing C (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3–23

    Article  Google Scholar 

  4. Meierkord H, Boon P, Engelsen B, Gocke K, Shorvon S, Tinuper P, Holtkamp M (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348–355

    Article  CAS  PubMed  Google Scholar 

  5. Ferlisi M, Shorvon S (2012) The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 135:2314–2328

    Article  PubMed  Google Scholar 

  6. Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Eng J Med 366:591–600

    Article  CAS  Google Scholar 

  7. Alvarez V, Januel JM, Burnand B, Rossetti AO (2011) Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia 52:1292–1296

    Article  CAS  PubMed  Google Scholar 

  8. Yasiry Z, Shorvon SD (2014) The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure 23:167–174

    Article  PubMed  Google Scholar 

  9. Kellinghaus C, Berning S, Stogbauer F (2014) Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand 129:294–299

  10. Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J, Fountain N, Jones E, Lowenstein D, Shinnar S, Silbergleit R, Treiman D, Trinka E, Kapur J (2013) The established status epilepticus trial 2013. Epilepsia 54[Suppl 6]:89–92

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW (2011) A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 14:4–10

    Article  CAS  PubMed  Google Scholar 

  12. Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM, Al-Otaibi A, Kilbride R, Fernandez IS, Mendoza L, Samuel S, Zakaria A, Kalamangalam GP, Legros B, Szaflarski JP, Loddenkemper T, Hahn CD, Goodkin HP, Claassen J, Hirsch LJ, Laroche SM (2013) Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 54:1498–1503

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM (2013) Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 105:183–188

    Article  CAS  PubMed  Google Scholar 

  14. Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, Kaplan PW, Geocadin RG, Hartman AL, Venkatesan A, Cervenka MC (2014) Ketogenic diet for adults in super-refractory status epilepticus. Neurology 82:665–670

    Article  CAS  PubMed  Google Scholar 

  15. Ferguson M, Bianchi MT, Sutter R, Rosenthal ES, Cash SS, Kaplan PW, Westover MB (2013) Calculating the risk benefit equation for aggressive treatment of non-convulsive status epilepticus. Neurocrit Care 18:216–227

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Rossetti AO, Alvarez V, Januel JM, Burnand B (2013) Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 260:421–428

    Article  PubMed  Google Scholar 

  17. Kowalski RG, Ziai WC, Rees RN, Werner JK Jr, Kim G, Goodwin H, Geocadin RG (2012) Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 40:2677–2684

    Article  CAS  PubMed  Google Scholar 

  18. Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S (2014) Anesthetic drugs in status epilepticus: risk or rescue?: A 6-year cohort study. Neurology 82:656–664

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

AOR received research support from Sage Therapeutics, UCB anmd EISAI. He's supported by the Swiss National Science Foundation (grant nr. CR32I3_143780).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrea O. Rossetti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossetti, A.O., Bleck, T.P. What’s new in status epilepticus?. Intensive Care Med 40, 1359–1362 (2014). https://doi.org/10.1007/s00134-014-3363-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-014-3363-z

Keywords

Navigation